US EditionPhilips Gets Warning Letter From US FDA on Device Facilities
4 Articles
4 Articles
Philips has received a warning letter from the FDA, the US medical watchdog. The electronics company allegedly failed to meet production standards at three locations. These include the Philips plant in Eindhoven and two locations in the United States. The FDA inspected nine facilities this year. Three factories were found to be failing to comply with procedures for the responsible production of medical equipment such as ultrasound machines. No r…
Philips Gets Warning Letter From US FDA on Device Facilities
Philips received a letter from the US Food and Drug Administration warning the medical equipment maker that three of its device facilities in the US and the Netherlands didn’t comply with manufacturing standards.
FDA hits Philips with warning over manufacturing site deficiencies
The US Food and Drug Administration (FDA) has hit Philips with a warning letter after quality control shortcomings were uncovered at three of its medical device manufacturing sites.The post FDA hits Philips with warning over manufacturing site deficiencies appeared first on Medical Device Network.
Philips closed lower on the Amsterdam AEX index on Tuesday, following a warning letter from the US Food and Drug Administration (FDA). The watchdog informed the healthcare technology company that three of its production facilities in the United States and the Netherlands do not meet production standards. The share price fell 6 percent.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
